Seeking Alpha

Amarin (AMRN -5.9%) took a big hit today after noting in a filing yesterday that it doesn't...

Amarin (AMRN -5.9%) took a big hit today after noting in a filing yesterday that it doesn't expect a decision from the FDA this month on the exclusivity of its heart pill Vascepa. This marks the second straight month a decision on Vascepa has failed to make the FDA's monthly "Orange Book" update. The ruling is a highly anticipated one that could award the company sole marketing rights to the drug.
Comments (10)
  • Moosh
    , contributor
    Comments (125) | Send Message
     
    Oh my GOD, I am terrified...Selling all my shares after hours))))
    Long Amrn
    11 Sep 2012, 06:29 PM Reply Like
  • Gdscharf62
    , contributor
    Comments (2) | Send Message
     
    Staying on the ship. It's a good drug with great benefits. I will wait for the return!
    11 Sep 2012, 09:05 PM Reply Like
  • tdwhelan2004
    , contributor
    Comments (2) | Send Message
     
    R U PREDICTING A TAKEOVER OF AMARIN
    12 Sep 2012, 12:57 AM Reply Like
  • dominickcosta
    , contributor
    Comments (2) | Send Message
     
    I'm staying on the ship. Great drug and I suspect a big pharma company will buy them out sooner rather than later.
    According to some analysts the stock price could between $18.00 - $22.00 depending on circumstances.
    12 Sep 2012, 12:44 AM Reply Like
  • Leggetb
    , contributor
    Comments (2) | Send Message
     
    Also staying on board. If AMRN drops another 5% I will add shares. Real results will post around next quarter update in November with possible NDA approvals next month. Good drug, valid data, excellent prospects for more appreciation.
    12 Sep 2012, 12:46 AM Reply Like
  • gostockyourself
    , contributor
    Comments (101) | Send Message
     
    there wont be any results next quarter, this is going down for now. im completly on board but no reason to buy at this level if you already own, i'd wait for $6-8. this will likely mirror DNDN price action right after approval. they dont start selling until 2013, so we wont have results until APRIL 2013. thats 6 months of speculated stock action. have fun!
    12 Sep 2012, 08:55 AM Reply Like
  • tdwhelan2004
    , contributor
    Comments (2) | Send Message
     
    The upside far outwieghs the downside. Great product which will bring investors profit in the near future.
    12 Sep 2012, 12:58 AM Reply Like
  • mitrado
    , contributor
    Comments (1949) | Send Message
     
    If it were not for weasels like Adam Feuerstein, this stock would move higher, a lot faster. That little troll takes every opportunity he gets to spread rumours and misinformation about AMRN, SPPI and a lot other companies.

     

    He is truly ridiculous... and his behaviour seems almost intentionally criminal.

     

    Adam's using his free speech... right?

     

    Then I'll use mine: please check the following page for some facts on Adam Feuerstein: http://bit.ly/zcz1QE

     

    Please spread this page as much as you can.

     

    The sooner he is exposed, the sooner we can all invest without a constant fear of a dishonest guy bashing our stocks.
    12 Sep 2012, 06:02 AM Reply Like
  • DAVE 01
    , contributor
    Comment (1) | Send Message
     
    AMRN, has awesome product , don't sell now. This stock should be between 16.00 and 30.00 soon
    3 Oct 2012, 10:51 PM Reply Like
  • mitrado
    , contributor
    Comments (1949) | Send Message
     
    Sure... and SPPI should never be trading with such a ridiculously low P/E but this is a criminals' market.

     

    Anyway, with 67% short float... any kind of short covering on SPPI would be epic. They'd probably need over a month to cover all those outstanding shares...
    4 Oct 2012, 03:54 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|